Ticker Details
Cytokinetics, Incorporated Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
IPO Date:	May 1, 2004
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$9.22B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.47 | 3.07%
Avg Daily Range (30 D):	$1.86 | 2.62%
Avg Daily Range (90 D):	$1.46 | 2.17%

Institutional Daily Volume
Avg Daily Volume:	.61M
Avg Daily Volume (30 D):	2.6M
Avg Daily Volume (90 D):	1.87M

Trade Size
Avg Trade Size (Sh.):	99
Avg Trade Size (Sh.) (30 D):	73
Avg Trade Size (Sh.) (90 D):	65

Institutional Trades
Total Institutional Trades:	8,831
Avg Institutional Trade:	$3.46M
Avg Institutional Trade (30 D):	$4.83M
Avg Institutional Trade (90 D):	$4.66M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$7.77M
Avg Closing Trade (30 D):	$26.77M
Avg Closing Trade (90 D):	$20.44M
Avg Closing Volume:	182.73K

News

May 27, 2026 @ 8:00 PM Cytokinetics to Participate in June Investor Confe... Source: Na

May 18, 2026 @ 8:00 PM Cytokinetics Announces Inducement Grants Under Nas... Source: Na

May 12, 2026 @ 8:00 PM Cytokinetics to Participate in the 2026 RBC Capita... Source: Na

Apr 21, 2026 @ 8:00 PM Cytokinetics to Announce First Quarter Results on ... Source: Na

Mar 23, 2026 @ 5:17 PM Biohaven Stock Down 70% but One Fund's New $6 Mill... Source: Jonathan Ponciano

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-6.84	$-1.67	$-1.5
Diluted EPS	$-6.84	$-1.67	$-1.5
Revenue	$105.82M	$19.36M	$17.76M
Gross Profit
Net Income / Loss	$-829.61M	$-206.03M	$-183.03M
Operating Income / Loss	$-640.25M	$-183.62M	$-178.37M
Cost of Revenue
Net Cash Flow	$58.9M	$7.32M	$-102.95M
PE Ratio

Splits
Jun 25, 2013	1:6